Testicular cancer and Hodgkin disease in the same patient
- 1 May 1993
- Vol. 71 (9) , 2838-2840
- https://doi.org/10.1002/1097-0142(19930501)71:9<2838::aid-cncr2820710926>3.0.co;2-i
Abstract
Background. Although testicular cancer and Hodgkin disease are the neoplasms with the highest incidence in young men, only 13 cases of metachronous and 2 cases of synchronous occurrence in the same person were reported before 1991. Methods. A 30-year-old man is described, in whom, 2 years after radiation therapy for Stage IIIA Hodgkin disease, a testicular nonseminomatous germ cell tumor developed with metastatic spread to the retroperitoneal lymph nodes, lung, and left supraclavicular fossa. The second case report describes a 31-year-old man in whom a metastasizing nonseminomatous testicular cancer, with elevation of levels of the serum tumor markers alpha-fetoprotein and human chorionic gonadotropin, developed simultaneously with axillary lymphadenopathy that was histologically confirmed Hodgkin disease. Results. After five cycles of cisplatin-based chemotherapy and secondary retroperitoneal lymphadenectomy, the patient with metachronous disease has remained in complete remission for 8 years. The patient with synchronous occurrence has been disease-free for 14 months after five cycles of chemotherapy consisting of cisplatin, etoposide, and doxorubicin (Adriamycin, Adria Laboratories, Columbus, OH). Conclusions. The metachronous and synchronous occurrence of testicular cancer and Hodgkin disease is a rare association of two curable neoplasms. The presence of both malignant neoplasms should be taken into consideration in young male patients, especially if disease distribution diverges from a regular pattern.Keywords
This publication has 13 references indexed in Scilit:
- Association of germ cell tumorsand Hodgkin's diseaseUrology, 1991
- Primary and salvage chemotherapy in advanced Hodgkin's disease: The Milan Cancer Institute experienceAnnals of Oncology, 1991
- Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or EtoposideNew England Journal of Medicine, 1987
- Second malignancies following testicular cancer, ovarian cancer and hodgkin's disease: An international collaborative study among cancer registriesInternational Journal of Cancer, 1987
- Hodgkin's disease during surveillance of Stage I testicular teratomaThe British Journal of Radiology, 1986
- Bleomycin-induzierte Lungeninfiltrate bei der Behandlung von HodenkarzinomenJournal of Molecular Medicine, 1984
- Curability of Advanced Hodgkin's Disease with ChemotherapyAnnals of Internal Medicine, 1980
- Large-Dose Bleomycin Therapy and Pulmonary ToxicityPublished by American Medical Association (AMA) ,1976
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPPCancer, 1975
- Bleomycin, an Antitumor AntibioticAnnals of Internal Medicine, 1972